Bulletin
Investor Alert

New York Markets Open in:

press release

March 22, 2022, 4:00 p.m. EDT

Alkermes to Participate in the Stifel 2022 CNS Days

DUBLIN, March 22, 2022 /PRNewswire/ -- Alkermes plc /zigman2/quotes/205084517/composite ALKS +1.72% announced today that its Chief Executive Officer, Richard Pops, will participate in a fireside chat at the Stifel 2022 CNS Days on Tuesday, March 29, 2022 at 8:30 a.m. ET (1:30 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com  and will be archived for 14 days.

About Alkermes plc Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at  www.alkermes.com .

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

 

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-stifel-2022-cns-days-301507471.html

SOURCE Alkermes plc

COMTEX_404598819/2454/2022-03-22T16:00:07

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

/zigman2/quotes/205084517/composite
US : U.S.: Nasdaq
$ 26.60
+0.45 +1.72%
Volume: 1.61M
Aug. 15, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$4.30 billion
Rev. per Employee
$530,696
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.